[HTML][HTML] The immune microenvironment in cartilage injury and repair

M Li, H Yin, Z Yan, H Li, J Wu, Y Wang, F Wei, G Tian… - Acta Biomaterialia, 2022 - Elsevier
The ability of articular cartilage to repair itself is limited because it lacks blood vessels,
nerves, and lymph tissue. Once damaged, it can lead to joint swelling and pain, accelerating …

Overview of MMP-13 as a promising target for the treatment of osteoarthritis

Q Hu, M Ecker - International journal of molecular sciences, 2021 - mdpi.com
Osteoarthritis (OA) is a common degenerative disease characterized by the destruction of
articular cartilage and chronic inflammation of surrounding tissues. Matrix metalloproteinase …

Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis

L Wang, C He - Frontiers in immunology, 2022 - frontiersin.org
Macrophages are the most abundant immune cells within the synovial joints, and also the
main innate immune effector cells triggering the initial inflammatory responses in the …

Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis

W Hu, Y Chen, C Dou, S Dong - Annals of the Rheumatic Diseases, 2021 - ard.bmj.com
Osteoarthritis (OA) is a degenerative joint disease in the elderly. Although OA has been
considered as primarily a disease of the articular cartilage, the participation of subchondral …

[HTML][HTML] The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review

K Sun, J Luo, J Guo, X Yao, X Jing, F Guo - Osteoarthritis and cartilage, 2020 - Elsevier
Osteoarthritis (OA) is a complicated degenerative disease that affects whole joint tissue.
Currently, apart from surgical approaches to treat late stage OA, effective treatments to …

Nanoparticle–cartilage interaction: pathology-based intra-articular drug delivery for osteoarthritis therapy

X Li, B Dai, J Guo, L Zheng, Q Guo, J Peng, J Xu… - Nano-micro letters, 2021 - Springer
Osteoarthritis is the most prevalent chronic and debilitating joint disease, resulting in huge
medical and socioeconomic burdens. Intra-articular administration of agents is clinically …

Insulin-like growth factor-1 in articular cartilage repair for osteoarthritis treatment

C Wen, L Xu, X Xu, D Wang, Y Liang… - Arthritis Research & …, 2021 - Springer
Articular cartilage repair is a critical issue in osteoarthritis (OA) treatment. The insulin-like
growth factor (IGF) signaling pathway has been implicated in articular cartilage repair. IGF-1 …

Cartilage tissue engineering: molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction

M Demoor, D Ollitrault, T Gomez-Leduc… - … et Biophysica Acta (BBA …, 2014 - Elsevier
Background Articular cartilage defects are a veritable therapeutic problem because
therapeutic options are very scarce. Due to the poor self-regeneration capacity of cartilage …

[HTML][HTML] The PI3K/Akt pathway: a critical player in intervertebral disc degeneration

ZH Ouyang, WJ Wang, YG Yan, B Wang, GH Lv - Oncotarget, 2017 - ncbi.nlm.nih.gov
Intervertebral disc degeneration (IDD) is thought to be the primary cause of low back pain, a
severe public health problem worldwide. Current therapy for IDD aims to alleviate the …

Effects and action mechanisms of individual cytokines contained in PRP on osteoarthritis

Z Wang, P Zhu, B Liao, H You, Y Cai - Journal of Orthopaedic Surgery and …, 2023 - Springer
Osteoarthritis (OA) is defined as a degenerative joint disease that can affect all tissues of the
joint, including the articular cartilage, subchondral bone, ligaments capsule, and synovial …